ABSTRACT Background: Food sources and intakes of zinc and heme iron may differ between Western and Asian populations. However, all of the studies on the association between zinc and heme iron intakes and colorectal cancer have been conducted in Western populations. Objective: We investigated the association between zinc and heme iron intakes and colorectal cancer risk in a Japanese general population. Design: We conducted a large, population-based prospective study in 39,721 men and 45,376 women aged 45-74 y. Heme iron and zinc intakes were measured by using a validated food-frequency questionnaire in either 1995 or 1998. Results: During as many as 808,053 person-years of follow-up until the end of 2006, 1284 colorectal cancer cases were identified. In multivariate-adjusted models, zinc and heme iron intakes were not associated with colorectal cancer in either men or women. In comparison with the lowest quartile, the HRs (95% CIs) for developing colorectal cancer in the fourth quartile of zinc and heme iron intakes were 0.77 (0.58, 1.03; P-trend = 0.2) and 1.06 (0.79, 1.42; P-trend = 0.6), respectively, for men and 1.05 (0.77, 1.44; P-trend = 0.4) and 0.88 (0.61, 1.29; P-trend = 0.4), respectively, for women. Conclusion: Our results in a Japanese population with lower intakes and different major food sources of zinc and heme iron in comparison with those of Western populations suggest that zinc and heme iron intakes are not associated with colorectal cancer.
INTRODUCTION
A recent joint report by the World Cancer Research Fund and the American Institute for Cancer Research concluded that there was "convincing" evidence to support a positive association between colorectal cancer (CRC) and intakes of both red and processed meats (1). Red meat is rich in zinc and heme iron. Zinc is an antioxidant and is involved in various cellular functions, including DNA repair and apoptosis (2) , whereas heme iron is a prooxidant and may contribute to colorectal carcinogenesis by promoting free radical production and lipid peroxidation (3) (4) (5) .
Only 3 prospective studies (6) (7) (8) and one case-control study (9) have examined an association of dietary zinc intake with CRC risk, whereas several studies have reported an association between heme iron intake and CRC risk (6) (7) (8) (10) (11) (12) (13) . However, all of these studies were conducted in Western populations, and we know of no data reported for prospective cohort studies in Asian general populations. Food sources of zinc and heme iron might differ between Western and Asian populations, because Asian populations tend to consume more fish (14) and poultry (15) and less red meat (16) than do Western populations. Therefore, similar studies in Asian populations are important to confirm the generalizability of these associations.
In addition, zinc and heme iron concentrations may be modified by alcohol consumption. For example, serum zinc concentrations in alcohol-drinking patients are reportedly lower than those in nondrinkers (17) , and this difference may be due to an ethanolinduced increase in urinary zinc excretion (18) . In addition, alcohol consumption is known to disrupt iron homeostasis (19) (20) (21) (22) . Some previous studies have reported that associations of CRC with zinc or heme iron intake are more pronounced among alcohol drinkers (6, 7, 10) .
Vitamins B-6 and B-12, which are plentiful in foods rich in zinc and heme iron, such as meat and fish, may also affect the association between zinc and heme iron intakes and CRC risk. We previously reported that vitamins B-6 and B-12 are associated with decreased and increased risk of CRC, respectively (23) . Discrepancies between the results of previous studies may be due to confounding or effect modification of vitamin B-6 or vitamin B-12, which was not taken into account previously. Therefore, more studies that consider vitamins B-6 and B-12 as confounding factors are needed.
Here, we investigated the association between zinc and heme iron intakes and CRC risk in a population-based, prospective cohort study in Japan. Our hypothesis was that a higher intake of zinc would decrease CRC risk, whereas higher heme iron intake would increase CRC risk. We also considered the effects of vitamin B-6 and B-12 intakes on CRC risk and tested whether any associations depended on alcohol consumption.
SUBJECTS AND METHODS

Study population
The Japan Public Health Center-based Prospective Study was initiated in 1990 for cohort I and in 1993 for cohort II. Participants were all registered Japanese inhabitants of 11 public health center areas and were aged 40-69 y (cohort I: 40-59 y; cohort II: 40-69 y) at the beginning of each cohort's baseline survey. Details of the study design have been described previously (24) . The institutional review board of the National Cancer Center, Tokyo, Japan, approved the study. The participants in the present study were subjects in the Japan Public Health Center study who responded to a 5-y follow-up questionnaire during the period from 1995 to 1999 at ages 45-74 y. The present study used the 5-y follow-up survey as a baseline because this survey included a detailed self-administered foodfrequency questionnaire (FFQ). The participants from 2 public health center areas (Tokyo and Osaka) were excluded from the present analysis because the selection criteria of participants differed from those in other public health center areas, which left 116,896 participants as the study population. After the exclusion of non-Japanese participants (n = 51), late reports of emigration occurring before the starting point (n = 168), ineligibility due to incorrect birth date (n = 4), and duplicate enrollments (n = 4), we established a population-based cohort of 116,669 participants. After the exclusion of 1626 participants who had died, moved out of the study area, or were lost to follow-up before the starting point, 115,043 eligible participants remained. From these, 91,245 responded to the questionnaire, yielding a response rate of 79.3%. We excluded participants who had been diagnosed with or reported as having CRC before the starting point (n = 605) or who reported extreme total energy intakes (upper 2.5% or lower 2.5%; n = 5543). The final analysis included 85,097 participants (39,721 men and 45,376 women).
Questionnaire
We asked participants to reply to a lifestyle questionnaire that covered sociodemographic characteristics, medical history, smoking and drinking habits, and diet. We designed the FFQ to estimate dietary intake from 138 food items and validated it for the estimation of various nutrients and food groups (25) . The participants were asked to estimate how often they consumed the individual food items (frequency of intake) and to estimate representative relative portion sizes compared with standard portions during the previous year (26) . The FFQ contained questions on frequency (never, 1-3 times/mo, 1-2 times/wk, 3-4 times/wk, 5-6 times/wk, once per day, 2-3 times/d, 4-6 times/d, or $7 times/d) and portion sizes relative to a standard portion [small (50% smaller), medium (same as standard), and large (50% larger)]. Daily food intake was calculated by multiplying frequency by standard portion and relative size for each food item in the FFQ. Daily intakes of zinc and iron were calculated by using the Fifth Revised and Enlarged Edition of the Standard Tables of Food Composition in Japan (27) . Heme iron intake was calculated by multiplying type-specific percentages of heme iron by total iron content (mg/g) to yield heme iron contents for the reported intake of 16 meat items (7 food groups) and 19 fish and shellfish items (one food group); the percentages of heme iron used for the various types of meat, fish, and shellfish were as follows: 69% for beef; 39% for pork, ham, bacon, and luncheon meat; 26% for chicken, fish, and shellfish (10, 12) ; and 21% for liver (12) . We did not collect information on the use of iron and zinc supplements, because zinc and iron supplementation is reported to be low in Japan (,0.5% in both men and women, and 0.2% in men and 2.4% in women, respectively) (28) . Intakes of food and nutrients were log-transformed and adjusted for total energy intake by means of the residual model (29) .
The validity of the energy-adjusted zinc or iron intake assessed from the 5-y FFQ was evaluated in a subsample with consecutive 14-or 28-d dietary records. Spearman's correlation coefficients between the energy-adjusted intakes of zinc and iron from the questionnaire and from dietary records were 0.50 and 0.44 (cohort I) and 0.44 and 0.54 (cohort II), respectively, for men and 0.35 and 0.38 (cohort I) and 0.40 and 0.55 (cohort II), respectively, for women (30) . We also calculated Spearman's correlation coefficients between the energy-adjusted heme iron intakes from the questionnaire and from dietary records in cohorts I and II: 0.26 and 0.28 for men and 0.11 and 0.27 for women, respectively (A Hara, unpublished data, 2012).
Follow-up and identification of CRC cases
We followed participants from the 5-y follow-up survey until 31 December 2006. We identified changes in residence status (including survival) annually through the residential registry in each area or, for those who had moved out of the area, through the municipal office of the area to which they had moved. Mortality data for persons in the residential registry are forwarded to the Ministry of Health, Labor, and Welfare and are coded for inclusion in the national vital statistics database. Residency registration and death registration are required by the Basic Residential Register Law and the Family Registry Law, respectively, and the registries are thought to be complete. During the follow-up period in the present study, 9425 (11.1%) participants died, 3695 (4.4%) moved out of the study area, and 308 (0.4%) were lost to follow-up.
We identified incidence data for CRC by active patient notification from major local hospitals in the study area and from data linkage with population-based cancer registries. We coded CRC cases according to the International Classification of Diseases for Oncology, third edition (31) (C18-C20). We conducted analyses of site-specific cancers: C18 for colon cancer (C18.0-C18.5 for proximal colon cancer and C18.6-C18.7 for distal colon cancer) and C19 and C20 for rectal cancer. In our cancer registry system, the proportion of cases for which information was available from death certificates only was 2.7%.
Statistical analysis
We calculated person-years of follow-up for each participant from the starting point to the date of CRC diagnosis, date of emigration from the study area, date of death, or end of the follow-up (31 December 2006), whichever came first. We censored ZINC, HEME IRON, AND COLORECTAL CANCER RISK participants lost to follow-up at the last confirmed date of presence in the study area.
We calculated HRs and 95% CIs for developing CRC for the categories of energy-adjusted intakes of zinc and heme iron in quartiles for men and women separately, with the lowest consumption category as the reference. We used Cox proportional hazards models with adjustment for potential confounding variables as follows: age (y); public health center area; BMI (in kg/ m 2 ; ,18.4, 18.5-19.9, 20-22.4, 22.5-24.9, 25-29.9, or $30); smoking status (never, past, or current); alcohol consumption (for men-none; drinker: ,150, 150-299, 300-449, or $450 g ethanol/wk; for women-none; drinker: ,150 or $150 g ethanol/wk); quartile of physical activity in metabolic equivalent task-hours/d; history of type 2 diabetes (yes or no); screening examinations for CRC (fecal occult blood test, barium enema, or colonoscopy); menopausal status (premenopausal or natural or induced postmenopausal) and use of exogenous female hormones (never or ever) in women; and quartiles of energyadjusted intakes of calcium, magnesium, vitamin B-6, vitamin B-12, folic acid, vitamin D, n23 PUFAs, and fiber.
We calculated P values for the analyses of linear trends by assigning ordinal values for categories of zinc and heme iron intakes and entering the values as continuous terms in the regression model. We also statistically evaluated the interactions between sex and zinc and heme iron intakes and between alcohol consumption and zinc and heme iron intakes with regard to the risk of CRC based on the likelihood ratio test with 1 df. The interaction was assessed by a product term consisting of a dichotomous variable for alcohol drinking and an ordinal variable for heme or zinc. We then created an interaction term by multiplying the dichotomous value for alcohol consumption by ordinal values for zinc or heme iron intake. All P values are 2-sided, and significance was determined at the P , 0.05 level. We performed all statistical analyses with SAS software, version 9.1 (SAS Institute Inc).
RESULTS
During 808,053 person-years of follow-up, we identified 1284 new CRC cases (786 for men, 498 for women).
The major sources of zinc in our population were grains (37%), red meat (15%), pulses (9.5%), dairy products (9.2%), and fish (9.1%). Dietary heme iron was derived mainly from various types of fish and shellfish (49%), beef (20%), and pork, ham, bacon, and luncheon meat (19%).
The characteristics of participants according to zinc and heme iron intakes are shown in Tables 1 and 2 for men and women, respectively. Mean (6SE) zinc and heme iron intakes were 8.5 6 0.007 and 0.50 6 0.001 mg/d, respectively, in men and 7.9 6 0.004 and 0.44 6 0.001 mg/d, respectively, in women. Men and women with a high intake of zinc were less likely to be drinkers (alcohol consumption $1 g ethanol/wk), were more likely to have a history of type 2 diabetes, and generally consumed more of most of the foods and nutrients listed in Tables 1 and 2 , compared with those with a low intake of zinc. Men with a higher zinc intake were less likely to be ever smokers, and women with a higher zinc intake were more likely to be postmenopausal. Both men and women whose heme iron intakes were higher were more likely to consume zinc, vitamin D, vitamin B-6, vitamin B-12, n23 PUFAs, fish, and red meat and less likely to consume calcium and fiber compared with those whose heme iron intakes were lower. In men, individuals with a higher heme iron intake were less likely to be drinkers than those with a lower heme iron intake. The relations between magnesium, folate, and vegetable intakes and heme iron intake for men differed from the relations for women.
Associations between zinc and heme iron intakes and CRC risk in men and women are shown separately (Tables 3 and 4, respectively). In an age-and area-adjusted model, the quartile category of zinc intake was associated with decreased risk of colorectal, colon, and rectal cancer in men, whereas heme iron intake was not associated with CRC risk. However, in multivariate-adjusted models, zinc intake was not significantly associated with the risk of CRC among men; the HRs (95% CIs) for the highest quartile compared with the lowest quartile of zinc intake were 0.77 (0.58, 1.03) for colorectal, 0.76 (0.54, 1.07) for colon, and 0.80 (0.49, 1.32) for rectal cancer. Heme iron intake was not associated with CRC risk, whereas we found significantly higher HRs for vitamin B-12 intake and lower HRs for vitamin B-6 intake in the higher-intake categories in the same multivariate-adjusted model; the HRs (95% CIs) for the highest quartile compared with the lowest quartile were 1.52 (1.05, 2.20; P-trend = 0.01) and 0.68 (0.49, 0.94; P-trend = 0.009), respectively. Similar results were observed when we evaluated the risk of either proximal or distal colon cancer (data not shown). In women, there was no significant association between zinc and heme iron intakes and CRC risk in the age-and area-adjusted model or in the multivariate-adjusted model. Results were essentially unchanged when analyses were restricted to postmenopausal women (data not shown). There was no statistical interaction between sex and zinc or heme iron intakes with regard to the risk of CRC (all P values for interaction were .0.1).
The results of stratified analysis by alcohol intake among men are shown in Table 5 . We found no significant interactions (all P values for interaction were .0.07), although a significant inverse association between zinc intake and CRC risk was observed only among drinkers; HRs (95% CIs) for the highest quartile compared with the lowest quartile of zinc intake were 0.63 (0.47, 0.85; P-trend = 0.001) for colorectal, 0.62 (0.43, 0.89; P-trend = 0.01) for colon, and 0.67 (0.39, 1.13; P-trend = 0.04) for rectal cancer. However, among drinkers, the doseresponse was not clear; the HR for men who consumed more alcohol ($450 g/wk) was similar to those who consumed less alcohol (,150 g/wk) in the highest quartile of zinc intake. No significant association was observed between heme iron intake and CRC risk in the analysis stratified by alcohol intake. These effects of alcohol intake could not be examined in women, because the number of women who consumed $150 g alcohol/wk was insufficient. The results among all nondrinkers in women were similar to the results among all women; the HRs (95% CI) for the highest quartile compared with the lowest quartile were 1.10 (0.77, 1.57; P-trend = 0.3) for zinc intake and 0.88 (0.58, 1.33; P-trend = 0.4) for heme iron intake.
DISCUSSION
To our knowledge, our study is the first large-scale prospective cohort study to evaluate the effect of heme iron and zinc intakes on CRC risk in Asia, where the dietary sources of zinc and heme iron differ from those in Western countries. Zinc and heme iron intakes were not significantly associated with CRC risk. We found an inverse association between zinc intake and CRC risk among drinkers in men, although there were no significant interactions.
Food sources of zinc and heme iron vary among ethnic groups and cultures. In the Western diet, the major food sources of dietary zinc are red meat, poultry, dairy foods, whole grains, and fortified cereals (7, 8) , whereas in our study's Japanese population, the main sources were grains, red meat, pulses, dairy products, and fish. Fish was also the main food source of heme iron in our study. To date, only 3 cohort studies (6) (7) (8) and one case-control study (9) have examined the association between zinc intake and CRC risk, and all of these studies involved Western populations. The results indicated a decreased risk of CRC of zinc intake in 2 studies from the United States (6, 8) and one from Australia (9) but not in a study from Sweden (7) . In the present study, we observed no significant association between zinc intake and CRC risk in the general population of Japan, where the major food sources of zinc differ from those in Western countries and where zinc intake is lower than that in Western countries; the intake ranges of the third quintiles in Western studies were 9.7-10.3 mg/d (7) to 11.5-14.8 mg/d (6) . Six cohort studies reported an association between heme iron intake and CRC risk, but the association remains controversial (6) (7) (8) (10) (11) (12) . A recent meta-analysis of 5 of these studies suggests a modest positive association between heme iron intake and colon cancer risk (highest quintile compared with lowest quintile; HR: 1.18; 95% CI: 1.06, 1.32) (13) . The controversy may be due to confounding or effect modification of vitamin B-6 or vitamin B-12, which was not taken into account previously. These vitamins are present in some of the same foods as heme iron, such as meat and fish (27) (the correlation coefficients between vitamins B-6 and B-12 and heme iron in this study were 0.40 and 0.58 in men and 0.31 and 0.54 in women, respectively). In addition, we previously reported that higher vitamin B-6 intake is associated with a decreased risk of CRC, whereas high vitamin B-12 intake tends to increase CRC risk (P-trend = 0.05) in men (23) . Vitamins B-6 and B-12 are coenzymes in onecarbon metabolism, which is critical for the synthesis and methylation of DNA (32, 33) . Low dietary intake of these nutrients may result in colon carcinogenesis via the induction of aberrations in DNA methylation and synthesis (34, 35) . However, high concentrations of vitamin B-12 may also induce hypermethylation in this pathway. Associations of vitamin B-12 with DNA methylation have been observed in rats (36, 37) and humans (38, 39) , although the idea that DNA methylation is a cause of CRC remains speculative. In the present study, we found significantly higher CRC risk associated with high vitamin B-12 intake, lower CRC risk associated with high vitamin B-6 intake, and no association of CRC risk with heme iron intake in the multivariate model. These findings suggest that heme iron intake may only partly explain the apparent increased risk of CRC and that other factors present in foods along with heme iron, such as vitamin B-12, might be involved in colorectal carcinogenesis. In addition, differences in other constituents of the major food sources of heme iron between Western and Japanese populations might have produced the different associations with CRC risk observed in previous studies and the present study. Major sources of heme iron in Western populations are red and processed meats. Other constituents of red and processed meats, such as nitrate and heterocyclic amines, reportedly increase CRC risk (11) . In contrast, fish and shellfish were the major sources of heme iron in the Japanese population. These foods also include nutrients such as n23 PUFAs and vitamin D, which protect against CRC (40, 41) . In the present study, we observed a significant inverse association between high zinc intake and CRC risk among drinkers in men. However, there was no significant interaction and the doseresponse was not clear, which suggests that the inverse association between zinc intake and CRC risk among drinkers in men might be a random finding. Alternatively, the study might be underpowered to detect the significant interaction between alcohol consumption and zinc intakes with regard to CRC risk. Further research in a large population is needed to investigate the interaction with alcohol consumption.
The strength of this study was its prospective design, which enabled us to avoid exposure recall bias. Participants were selected from the general population, the sample size was large, the response rate for the surveys was acceptable for studies of settings such as this, and the loss to follow-up was negligible. In addition, the cancer registry was of sufficient quality to reduce misclassification of the outcomes.
Several limitations of the study warrant mention. First, we assessed zinc and iron intakes by using an FFQ, and heme iron content values were calculated on the basis of type-specific percentages of total iron content. In addition, in our FFQ, we included only 2 types of shellfish that were rich in zinc. Therefore, there may have been some misclassification of zinc and heme iron intakes. Especially for heme iron intake in women, the lower validity of the FFQ (r = 0.11-0.27 for women) may have resulted in the misclassification of individual intakes. The lack of association between heme iron intake and CRC risk among women in the present study may have been due partly to the poor validity of the FFQ for heme iron intake. However, no previous study has reported the validation of heme iron intake from an FFQ. Two studies showed the validation of iron intake (8) or major food sources of dietary heme iron, such as red meat and processed meat (8, 10) , but none of the other studies showed the validation of heme iron intake (6, 7, 9, 11, 12) . Therefore, we could not compare our validation of heme iron intake to validations in previous studies. Second, we did not collect information on zinc and iron supplement use. However, a survey of supplement use in Japan from 2000 to 2002 showed that the prevalence of zinc and iron supplementation is low (,0.5% in both men and women and 0.2% in men and 2.4% in women, respectively) (28) , and thus we considered intake from supplements to be negligible. Third, although we measured and adjusted for possible confounding variables to the extent possible, the possibility of unmeasured confounding variables cannot be totally disregarded. Also, some of the significant findings may have been due to chance.
In conclusion, in this large-scale, population-based prospective cohort study in middle-aged Japanese men and women, whose 
